Trial Profile
A multicenter, randomized, parallel groups, placebo-controlled study comparing the efficacy, safety, and tolerability of the daily co-administration of ezetimibe 10 mg or ezetimibe placebo to ongoing treatment with atorvastatin 10 mg in subjects with primary hypercholesterolemia and coronary heart disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Feb 2022
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Organon; Schering-Plough
- 30 Sep 2008 Actual end date (Oct 2006) added as reported by ClinicalTrials.gov.
- 30 Sep 2008 Actual patient number (81) added as reported by ClinicalTrials.gov.
- 22 Nov 2006 Status change